Impact of GeneXpert MTB/RIF on Patients and Tuberculosis Programs in a Low-Burden Setting. A Hypothetical Trial

Rationale: Guidelines recommend routine nucleic-acid amplification testing in patients with presumed tuberculosis (TB), but these tests have not been widely adopted. GeneXpert MTB/RIF (Xpert), a novel, semiautomated TB nucleic-acid amplification test, has renewed interest in this technology, but dat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Respir Crit Care Med
Asıl Yazarlar: Davis, J. Lucian, Kawamura, L. Masae, Chaisson, Lelia H., Grinsdale, Jennifer, Benhammou, Jihane, Ho, Christine, Babst, Anna, Banouvong, Houmpheng, Metcalfe, John Z., Pandori, Mark, Hopewell, Philip C., Cattamanchi, Adithya
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Thoracic Society 2014
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226012/
https://ncbi.nlm.nih.gov/pubmed/24869625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201311-1974OC
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller